Cetera Trust Company’s AstraZeneca AZN Stock Holding History

Cetera Trust Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,373	Closed	-$436K	–	353
2025 Q4	$436K	Hold	2,373	–	–	0.23%	81
2025 Q3	$364K	Hold	2,373	–	–	0.2%	88
2025 Q2	$332K	Buy	2,373 +100	+4%	+$14K	0.2%	90
2025 Q1	$334K	Hold	2,273	–	–	0.21%	80
2024 Q4	$298K	Buy	2,273 +185	+9%	+$25.9K	0.19%	93
2024 Q3	$325K	Hold	2,088	–	–	0.2%	96
2024 Q2	$326K	Hold	2,088	–	–	0.2%	83
2024 Q1	$283K	Buy	2,088 +238	+13%	+$31.5K	0.17%	108
2023 Q4	$249K	Buy	+1,850	New	+$240K	0.16%	123

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Cetera Trust Company's AZN Position: Q1 2026 in Review

Cetera Trust Company sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 2,373 shares — an estimated $436K sold.

Cetera Trust Company first reported a position in AZN in Q4 2023 and held it in 9 quarters. The position peaked at $436K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Cetera Trust Company reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Cetera Trust Company sold 2,373 AstraZeneca shares in Q1 2026, an estimated $436K.
Cetera Trust Company first reported a position in AstraZeneca in Q4 2023 and held it in 9 quarters.
Cetera Trust Company's AstraZeneca position peaked at $436K in Q4 2025.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.